102 related articles for article (PubMed ID: 16945059)
21. Ziprasidone induced tardive cervical dystonia.
Kutlu A; Dündar S; Altun NS; Budak F
Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
[TBL] [Abstract][Full Text] [Related]
22. Ziprasidone-related oculogyric crisis in an adult.
Viana Bde M; Prais HA; Camargos ST; Cardoso FE
Clin Neurol Neurosurg; 2009 Dec; 111(10):883-5. PubMed ID: 19717224
[TBL] [Abstract][Full Text] [Related]
23. Ziprasidone-induced tardive laryngeal dystonia: a case report.
Tsai CS; Lee Y; Chang YY; Lin PY
Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the longitudinal study Ziprasidone Extended Use in Schizophrenia (ZEUS).
Bernardo M; Azanza JR; Rubio-Terrés C; Rejas J
Actas Esp Psiquiatr; 2007; 35(4):259-62. PubMed ID: 17592789
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
[TBL] [Abstract][Full Text] [Related]
27. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
Scott LK; Green R; McCarthy PJ; Conrad SA
J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
[TBL] [Abstract][Full Text] [Related]
28. Ziprasidone in the treatment of delayed carbon monoxide encephalopathy.
Hu MC; Shiah IS; Yeh CB; Chen HK; Chen CK
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):755-7. PubMed ID: 16581170
[TBL] [Abstract][Full Text] [Related]
29. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Schindehütte J; Trenkwalder C
Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
[TBL] [Abstract][Full Text] [Related]
30. Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone.
Zaidi AN
Ann Pharmacother; 2005 Oct; 39(10):1726-31. PubMed ID: 16131536
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy and atypical antipsychotics.
Ruzić K; Dadić-Hero E; Knez R; Medved P; Petrić D
Psychiatr Danub; 2009 Sep; 21(3):368-70. PubMed ID: 19794358
[TBL] [Abstract][Full Text] [Related]
32. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
33. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Montejo AL; Rico-Villademoros F;
J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
[No Abstract] [Full Text] [Related]
34. Pediatric ziprasidone overdose.
Fasano CJ; O'Malley GF; Lares C; Rowden AK
Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
[TBL] [Abstract][Full Text] [Related]
35. Profound hypothermia secondary to normal ziprasidone use.
Gibbons GM; Wein DA; Paula R
Am J Emerg Med; 2008 Jul; 26(6):737.e1-2. PubMed ID: 18606348
[TBL] [Abstract][Full Text] [Related]
36. Ziprasidone-associated mania: a review and report of 2 additional cases.
Keating AM; Aoun SL; Dean CE
Clin Neuropharmacol; 2005; 28(2):83-6. PubMed ID: 15795551
[TBL] [Abstract][Full Text] [Related]
37. Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
Montes JM; Rodriguez JL; Balbo E; Sopelana P; Martin E; Soto JA; Delgado JF; Diez T; Villardaga I
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):383-8. PubMed ID: 17129654
[TBL] [Abstract][Full Text] [Related]
38. A case of severe hyponatremia induced by duloxetine and ziprasidone.
Li RM; Wang C; Liu ZW; Zhao B
Chin Med J (Engl); 2012 Oct; 125(20):3750-1. PubMed ID: 23075738
[TBL] [Abstract][Full Text] [Related]
39. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
[TBL] [Abstract][Full Text] [Related]
40. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
Kinzie E; Meltzer-Brody S
Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
